Search Results - "Radulescu, Camelia"
-
1
PD-L1 testing in urothelial bladder cancer: essentials of clinical practice
Published in World journal of urology (01-05-2021)“…Purpose While immunotherapy has become an increasingly attractive strategy in patients with urothelial bladder cancer, the need for a biomarker to identify…”
Get full text
Journal Article -
2
Tim-3 Expression on Tumor-Infiltrating PD-1 + CD8 + T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
Published in Cancer research (Chicago, Ill.) (01-03-2017)“…Inhibitory receptors expressed by T cells mediate tolerance to tumor antigens, with coexpression of these receptors exacerbating this dysfunctional state…”
Get full text
Journal Article -
3
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
Published in The Journal of clinical investigation (15-06-2022)“…Patients with high-risk, nonmuscle-invasive bladder cancer (NMIBC) frequently relapse after standard intravesical bacillus Calmette-Guérin (BCG) therapy and…”
Get full text
Journal Article -
4
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer
Published in European journal of cancer (1990) (01-02-2019)“…Assessment of tumour-infiltrating lymphocytes (TILs) can provide important prognostic information in various cancers and may be of value in predicting response…”
Get full text
Journal Article -
5
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
Published in The lancet oncology (01-06-2015)“…Summary Background The likelihood of tumour recurrence after nephrectomy in localised clear cell renal cell carcinoma is well characterised by clinical and…”
Get full text
Journal Article -
6
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
Published in Nature communications (25-09-2019)“…Treatment of muscle-invasive bladder cancer remains a major clinical challenge. Aberrant HGF/c-MET upregulation and activation is frequently observed in…”
Get full text
Journal Article -
7
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC
Published in Urologic oncology (01-01-2022)“…•Plasmacytoid urothelial carcinomas (UC) represent a rare and aggressive variant with poor outcome and a low sensitivity to chemotherapy.•Phenotypically,…”
Get full text
Journal Article -
8
From arterial stiffness to kidney graft microvasculature: Mortality and graft survival within a cohort of 220 kidney transplant recipients
Published in PloS one (03-05-2018)“…Aortic stiffness assessed by carotid-femoral pulse wave velocity (CF-PWV) is a predictor of mortality in several populations. However, little is known in…”
Get full text
Journal Article -
9
Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance
Published in European urology (01-03-2011)“…Abstract Background The optimal selection of prostate cancer (PCa) patients for active surveillance (AS) is currently being debated. Objective To assess the…”
Get full text
Journal Article -
10
Immune checkpoints are predominantly co-expressed by clonally expanded CD4 + FoxP3 + intratumoral T-cells in primary human cancers
Published in Journal of experimental & clinical cancer research (06-12-2023)“…In addition to anti-PD(L)1, anti-CTLA-4 and anti-LAG-3, novel immune checkpoint proteins (ICP)-targeted antibodies have recently failed to demonstrate…”
Get full text
Journal Article -
11
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score
Published in PloS one (27-02-2019)“…To assess the prognostic value of multiple recurrences on the risk of progression in a large cohort of TaG1 bladder cancer of low and intermediate risk based…”
Get full text
Journal Article -
12
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial
Published in World journal of urology (01-09-2023)“…Purpose Cytology and cystoscopy, the current gold standard for diagnosing urothelial carcinomas, have limits: cytology has high interobserver variability with…”
Get full text
Journal Article -
13
A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models
Published in Nuclear medicine and biology (01-05-2020)“…Peptide-based imaging agents targeting prostate-specific membrane antigen (PSMA) have revolutionized the evaluation of biochemical recurrence of prostate…”
Get full text
Journal Article -
14
Sexual steroids in serum and prostatic tissue of human non‐cancerous prostate (STERPROSER trial)
Published in The Prostate (01-11-2017)“…Background The specific involvement of the sex steroids in the growth of the prostatic tissue remains unclear. Sex steroid concentrations in plasma and in…”
Get full text
Journal Article -
15
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy
Published in BJU international (01-07-2012)“…Study Type – Diagnostic (exploratory cohort) Level of Evidence 2b What's known on the subject? and What does the study add? PCA3 scores correlate to numerous…”
Get full text
Journal Article -
16
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results
Published in Hormones & cancer (01-02-2019)“…Failure rates after first-line treatment of localized prostate cancer (PCa) treatment remain high. Improvements to patient selection and identification of…”
Get full text
Journal Article -
17
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
Published in Nature communications (08-11-2019)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
18
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group
Published in Clinical genitourinary cancer (01-08-2020)“…Neuroendocrine carcinoma of the urinary bladder (NCUB) is rare, accounting for < 1% of bladder cancer cases, with scarce reported data available. We…”
Get full text
Journal Article -
19
Positive surgical margins after radical prostatectomy: What should we care about?
Published in World journal of urology (01-12-2015)“…Purpose Positive surgical margins (PSMs) after radical prostatectomy (RP) are a known factor associated with biochemical recurrence (BCR) and raise the issue…”
Get full text
Journal Article -
20
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non–muscle-invasive bladder cancer with positive results on urine cytology
Published in Urologic oncology (01-11-2014)“…Abstract Objective In accordance with the European Association of Urology guidelines, a second transurethral resection of the bladder (TURB) is recommended for…”
Get full text
Journal Article